Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05160389 · ClinicalTrials.gov registry record · Phase 1
A Study to Assess the Effect of Food on the Absorption and Bioavailability of PBI-200
A Phase 1 study of Food Effect in Healthy Volunteers, sponsored by Pyramid Biosciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT05160389 is a Phase 1 study of Food Effect in Healthy Volunteers that has completed, run by Pyramid Biosciences. The registered enrollment target is 16 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05160389, a Phase 1 study of Food Effect in Healthy Volunteers, has completed, sponsored by Pyramid Biosciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-dose, open-label, randomized, three-way crossover study to assess the effect of food on the absorption and bioavailability of PBI-200.
Conditions Studied
Interventions
- DRUG PBI-200
Study Locations (1)
Missouri
- Bio-Kinetic Clinical Applications - Springfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2021-11-17 |
| Est. Completion | 2022-01-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05160389
The ClinicalTrials.gov registry entry for NCT05160389 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pyramid Biosciences, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Food Effect in Healthy Volunteers appearing as the primary indexed condition, and to 1 intervention - of which PBI-200 is the first listed.
NCT05160389 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT05160389 about?
NCT05160389 is a clinical study titled "A Study to Assess the Effect of Food on the Absorption and Bioavailability of PBI-200". This is a single-dose, open-label, randomized, three-way crossover study to assess the effect of food on the absorption and bioavailability of PBI-200.
What is the current status of trial NCT05160389?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2021-11-17. Estimated completion is 2022-01-06.
What conditions does trial NCT05160389 study?
This clinical trial studies the following conditions: Food Effect in Healthy Volunteers.
What interventions are being tested in trial NCT05160389?
The interventions under investigation include: PBI-200 (DRUG).
Who is sponsoring clinical trial NCT05160389?
This trial is sponsored by Pyramid Biosciences, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05160389 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.